Adaptive Biotechnologies CSO Harlan S. Robins reports disposal of common shares worth $10.77 million
ADPT•CSO reports option exercise and share sales
Adaptive Biotechnologies Chief Scientific Officer Harlan S. Robins exercised options for 284,800 common shares at $6.55 on July 21, 2026.
Robins sold 492,400 common shares the same day at weighted-average prices of $21.72 and $22.12.
Directly held common shares fell to 812,058 following the transactions.
